Advisors Preferred »

Mereo Biopharma Group Plc ads shares owned by Advisors Preferred

Quarter-by-quarter ownership of Mereo Biopharma Group Plc ads (MREO) shares owned by Advisors Preferred from 13F filings

Historical chart of Advisors Preferred investment in Mereo Biopharma Group Plc ads

Tip: Access up to 7 years of quarterly data

All positions including Mereo Biopharma Group Plc ads held by Advisors Preferred consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mereo Biopharma Group Plc ads by Advisors Preferred

Quarter filed Position value Share count Share price at filing
2024-09-30 $76k 18k 4.17
2024-06-30 $90k 25k 3.63
2024-03-31 $28k 8.3k 3.41

More positions owned by Advisors Preferred

SPDR S&P 500 ETF Trust USD Class Etf (SPY)
Vanguard Financials ETF Etf (VFH)
iShares 20 plus Year Treasury Bond ETF USD Class Etf (TLT)
iShares 1-3 Year Treasury Bond ETF USD Class Etf (SHY)
Invesco Nasdaq 100 ETF USD Class Etf (QQQM)
iShares Russell 2000 Value ETF USD Class Etf (IWN)
Schwab US Dividend Equity ETF USD Class Etf (SCHD)
Vanguard Dividend Appreciation ETF USD Class Etf (VIG)
iShares 0-3 Month Treasury Bond ETF USD Class Etf (SGOV)
Premier (PINC)
iShares 7-10 Year Treasury Bond ETF USD Class Etf (IEF)
BondBloxx Bloomberg Six Month Target Duration US Treasury ETF Etf (XHLF)
Technology Select Sector SPDR Fund USD Class Etf (XLK)
Vanguard Long-Term Corporate Bond ETF USD Class Etf (VCLT)
WisdomTree US LargeCap Dividend Fund USD Class Etf (DLN)

View all positions for Advisors Preferred

Top funds holding Mereo Biopharma Group Plc ads

Rubric Capital Management
Rock Springs Capital Management
Henderson Group
Deerfield Management Company
Frazier Life Sciences Management
683 Capital Management
Clearline Capital
Tejara Capital
Goldman Sachs Group
Renaissance Technologies
Soleus Capital Management
Marshall Wace
Blue Owl Capital Holdings
NEOS Investment Management
Perceptive Advisors

View all funds holding Mereo Biopharma Group Plc ads